A
AsiaMedic Ltd
SGX:505
AsiaMedic Ltd
SGX:505
Price:
0.019
SGD
Market Closed
Market Cap:
S$21.5m
Balance Sheet
Balance Sheet Decomposition
AsiaMedic Ltd
AsiaMedic Ltd
Balance Sheet Decomposition is not available for
AsiaMedic Ltd
AsiaMedic Ltd
Balance Sheet
AsiaMedic Ltd
AsiaMedic Ltd
Currency: SGD
| Dec-2001 | Dec-2002 | Dec-2003 | Dec-2004 | Dec-2005 | Dec-2006 | Dec-2007 | Dec-2008 | Dec-2009 | Dec-2010 | Dec-2011 | Dec-2012 | Dec-2013 | Dec-2014 | Dec-2015 | Dec-2016 | Dec-2017 | Dec-2018 | Dec-2019 | Dec-2020 | Dec-2021 | Dec-2022 | Dec-2023 | Dec-2024 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets | |||||||||||||||||||||||||
| Cash & Cash Equivalents |
5
|
6
|
2
|
2
|
2
|
2
|
2
|
3
|
3
|
3
|
3
|
2
|
2
|
6
|
6
|
7
|
3
|
3
|
3
|
8
|
9
|
7
|
5
|
8
|
|
| Cash |
0
|
0
|
0
|
0
|
0
|
0
|
2
|
3
|
3
|
3
|
3
|
2
|
2
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Cash Equivalents |
5
|
6
|
2
|
2
|
2
|
2
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
6
|
6
|
7
|
3
|
3
|
3
|
8
|
9
|
7
|
5
|
8
|
|
| Short-Term Investments |
0
|
0
|
0
|
0
|
0
|
0
|
6
|
6
|
6
|
6
|
5
|
8
|
6
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
2
|
5
|
3
|
|
| Total Receivables |
2
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
2
|
1
|
1
|
1
|
2
|
4
|
2
|
2
|
2
|
2
|
3
|
3
|
3
|
3
|
3
|
5
|
|
| Accounts Receivables |
2
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
2
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
2
|
3
|
2
|
2
|
3
|
3
|
4
|
|
| Other Receivables |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
2
|
1
|
1
|
1
|
1
|
0
|
1
|
1
|
0
|
1
|
1
|
|
| Inventory |
1
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Current Assets |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
1
|
0
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
|
| Total Current Assets |
8
|
6
|
3
|
4
|
3
|
3
|
10
|
11
|
11
|
10
|
10
|
11
|
11
|
11
|
8
|
10
|
6
|
6
|
8
|
12
|
13
|
14
|
14
|
18
|
|
| PP&E Net |
4
|
1
|
6
|
6
|
8
|
6
|
6
|
6
|
6
|
5
|
4
|
4
|
7
|
7
|
9
|
8
|
5
|
4
|
9
|
2
|
4
|
8
|
11
|
26
|
|
| PP&E Gross |
4
|
1
|
6
|
6
|
8
|
6
|
6
|
6
|
6
|
5
|
4
|
4
|
7
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Accumulated Depreciation |
9
|
6
|
6
|
6
|
7
|
8
|
7
|
8
|
7
|
8
|
9
|
11
|
9
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Intangible Assets |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Goodwill |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
2
|
2
|
2
|
2
|
2
|
1
|
1
|
1
|
1
|
0
|
0
|
0
|
|
| Note Receivable |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
1
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Long-Term Investments |
1
|
1
|
2
|
2
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
2
|
2
|
2
|
2
|
2
|
2
|
2
|
2
|
2
|
2
|
2
|
2
|
2
|
|
| Other Long-Term Assets |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
1
|
0
|
0
|
0
|
0
|
0
|
1
|
1
|
|
| Other Assets |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
2
|
2
|
2
|
2
|
2
|
1
|
1
|
1
|
1
|
0
|
0
|
0
|
|
| Total Assets |
12
N/A
|
9
-31%
|
10
+21%
|
12
+13%
|
12
+7%
|
11
-11%
|
17
+51%
|
18
+5%
|
18
+0%
|
16
-9%
|
15
-8%
|
17
+14%
|
23
+36%
|
22
-3%
|
21
-6%
|
21
+1%
|
16
-26%
|
13
-18%
|
19
+48%
|
17
-12%
|
20
+20%
|
24
+18%
|
29
+22%
|
47
+61%
|
|
| Liabilities | |||||||||||||||||||||||||
| Accounts Payable |
1
|
1
|
1
|
1
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
1
|
1
|
1
|
2
|
1
|
1
|
1
|
1
|
1
|
2
|
2
|
|
| Accrued Liabilities |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
1
|
1
|
1
|
1
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Short-Term Debt |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Current Portion of Long-Term Debt |
0
|
0
|
1
|
1
|
1
|
1
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
2
|
2
|
1
|
1
|
1
|
2
|
1
|
1
|
1
|
2
|
2
|
|
| Other Current Liabilities |
0
|
0
|
0
|
0
|
1
|
1
|
1
|
1
|
1
|
0
|
0
|
1
|
3
|
2
|
3
|
4
|
3
|
3
|
3
|
3
|
3
|
3
|
3
|
5
|
|
| Total Current Liabilities |
2
|
1
|
2
|
2
|
3
|
2
|
2
|
2
|
3
|
1
|
1
|
2
|
7
|
5
|
6
|
6
|
6
|
5
|
6
|
5
|
5
|
5
|
7
|
9
|
|
| Long-Term Debt |
1
|
0
|
3
|
2
|
2
|
1
|
1
|
0
|
0
|
0
|
0
|
1
|
2
|
2
|
3
|
2
|
1
|
3
|
9
|
3
|
5
|
6
|
8
|
19
|
|
| Deferred Income Tax |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Minority Interest |
1
|
0
|
1
|
1
|
1
|
1
|
1
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
3
|
|
| Other Liabilities |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
0
|
0
|
0
|
0
|
1
|
1
|
1
|
1
|
1
|
1
|
2
|
|
| Total Liabilities |
4
N/A
|
1
-61%
|
5
+252%
|
5
-12%
|
5
+15%
|
4
-20%
|
4
-11%
|
3
-12%
|
3
-6%
|
2
-48%
|
1
-32%
|
3
+188%
|
10
+194%
|
8
-11%
|
9
+5%
|
8
-12%
|
7
-15%
|
9
+30%
|
15
+78%
|
9
-43%
|
11
+31%
|
13
+12%
|
16
+23%
|
32
+107%
|
|
| Equity | |||||||||||||||||||||||||
| Common Stock |
15
|
15
|
15
|
15
|
15
|
17
|
22
|
22
|
22
|
22
|
22
|
22
|
22
|
22
|
22
|
25
|
25
|
25
|
25
|
33
|
33
|
33
|
34
|
34
|
|
| Retained Earnings |
6
|
7
|
9
|
8
|
8
|
10
|
9
|
7
|
7
|
7
|
8
|
8
|
8
|
8
|
10
|
11
|
16
|
20
|
21
|
25
|
25
|
22
|
20
|
19
|
|
| Additional Paid In Capital |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Treasury Stock |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Equity |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Equity |
8
N/A
|
7
-17%
|
5
-28%
|
7
+38%
|
7
+2%
|
7
-4%
|
13
+91%
|
14
+10%
|
15
+1%
|
14
0%
|
14
-6%
|
14
+0%
|
14
-1%
|
14
+3%
|
12
-13%
|
13
+10%
|
9
-32%
|
4
-52%
|
4
-13%
|
8
+111%
|
9
+9%
|
11
+25%
|
13
+21%
|
14
+8%
|
|
| Total Liabilities & Equity |
12
N/A
|
9
-31%
|
10
+21%
|
12
+13%
|
12
+7%
|
11
-11%
|
17
+51%
|
18
+5%
|
18
+0%
|
16
-9%
|
15
-8%
|
17
+14%
|
23
+36%
|
22
-3%
|
21
-6%
|
21
+1%
|
16
-26%
|
13
-18%
|
19
+48%
|
17
-12%
|
20
+20%
|
24
+18%
|
29
+22%
|
47
+61%
|
|
| Shares Outstanding | |||||||||||||||||||||||||
| Common Shares Outstanding |
309
|
309
|
312
|
309
|
312
|
312
|
357
|
357
|
357
|
357
|
357
|
357
|
361
|
361
|
361
|
416
|
416
|
416
|
416
|
1 120
|
1 120
|
1 120
|
1 155
|
1 155
|
|
Switch to:
Switch to:
See Also
Discover More
